Vnitr Lek 2022, 68(1):19-25 | DOI: 10.36290/vnl.2022.003
Pacient s jaterní cirhózou na interním oddělení, intervence případného abúzu alkoholu
- 1 Interní klinika 2. LF UK a FN Motol, Praha
- 2 Adiktologická poradna, odborné pracoviště Area fausta, Praha
- 3 Kardiologická klinika 2. LF UK a FN Motol, Praha
- 4 Interní klinika 3. LF UK a FNKV, Praha
Published: February 14, 2022 Show citation
References
- Tsochatzis E A, J Bosch, and A K Burroughs. Liver cirrhosis. Lancet, 2014;383(9930):1749-1761.
Go to original source...
Go to PubMed...
- Kašpárek T, Dreisig M, Barteček R. Alkoholový odvykací stav a delirium - od patofyziologie k léčbě. Cesk Slov Neurol N 2014; 77/110(2): 153-157.
- Dugum M, McCullough A. Diagnosis and Management of Alcoholic Liver Disease. J Clin Transl Hepatol 2015;3(2):109-116. doi:10.14218/JCTH.2015.00008
Go to original source...
Go to PubMed...
- Haque LY, Jakab S, Deng Y, Ciarleglio MM, Tetrault JM. Substance Use Disorders in Recently Hospitalized Patients With Cirrhosis. J Addict Med 2020 Dec;14(6):e337-e343. doi: 10.1097/ADM.0000000000000677.
Go to original source...
Go to PubMed...
- Ehrmann J, Aiglová K, Konečný M, Procházka V, Vrzalová D. Aktuální možnosti léčby jaterní cirhózy v ambulanci internisty. Vnitr Lek. 2016;62(7-8):553-563.
Go to PubMed...
- Malinovská J, Kršková L, Švarcová B, Vejtasová V, Urbanová J, Brož J. Screening rizikového užívání alkoholu v ordinaci lékaře. Vnitr Lek. 2021;67(2):e38-43. doi: 10.36290/vnl.2021.033.
Go to original source...
- Wei J, Defries T, Lozada M, Young N, Huen W, Tulsky J. An inpatient treatment and discharge planning protocol for alcohol dependence: efficacy in reducing 30-day readmissions and emergency department visits. J Gen Intern Med. 2015 Mar;30(3):365-70. doi: 10.1007/s11606-014-2968-9.
Go to original source...
Go to PubMed...
- Addolorato G, Mirijello A, Leggio L, Ferrulli A, Landolfi R. Management of alcohol dependence in patients with liver disease. CNS Drugs. 2013;27(4):287-299. doi:10.1007/s40263-013-0043-4
Go to original source...
Go to PubMed...
- NCT04287920. ClinicalTrials.gov [online]. Dostupné z: https://clinicaltrials.gov/ct2/show/NCT04287920 (staženo 27. 3. 2022)
- Mellinger JL, Winder GS, Fernandez AC, Klevering K, Johnson A, Asefah H, Figueroa M, Buchanan J, Blow F, Lok ASF. Feasibility and early experience of a novel multidisciplinary alcohol‑associated liver disease clinic. J Subst Abuse Treat. 2021 Nov;130:108396. doi: 10.1016/j.jsat.2021.108396.
Go to original source...
Go to PubMed...
- European medicines agency. Disabling and potentially permanent side effects lead to suspension or restrictions of quinolone and fluoroquinolon antibiotics. European medicines agency [online]. Copyright © 2019 [cit. 09. 12. 2021]. Dostupné z: https://www.ema.europa.eu/en/documents/referral/quinolone‑fluoroquinolone‑article-31-referral‑disabling‑potentially‑permanent‑side‑effects‑lead_en.pdf
- Bonkat G. EAU guidelines on urological infections. European association of urology [online]. Copyright © 2021 [cit. 09. 12. 2021]. Dostupné z: https://uroweb.org/guideline/urological‑infections/
- de Franchis R, Baveno VIF: Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol 2015;63(3):743-752.
Go to original source...
Go to PubMed...
- Karstensen JG, Ebigbo A, Bhat P et al. Endoscopic treatment of variceal upper gastrointestinal bleeding: European Society of Gastrointestinal Endoscopy (ESGE) Cascade Guideline. Endosc Int Open 2020;8(7):E990-E997.
Go to original source...
Go to PubMed...
- Fejfar T, Vaňásek T, Brůha R et al. Léčba krvácení v důsledku portální hypertenze při jaterní cirhóze - aktualizace doporučených postupů ČHS ČLS JEP. Gastroenterol Hepatol 2017,71(2):105-116.
Go to original source...